Guided Therapeutics (GTHP) Short Interest Ratio & Short Volume $0.10 +0.00 (+4.17%) As of 02:25 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartEarningsSEC FilingsShort InterestBuy This Stock Guided Therapeutics Short Interest DataGuided Therapeutics (GTHP) has a short interest of 13,800 shares, representing 0.06% of the float (the number of shares available for trading by the public). This marks a 40.82% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 16,735 shares to cover all short positions.Current Short Interest13,800 sharesPrevious Short Interest9,800 sharesChange Vs. Previous Month+40.82%Dollar Volume Sold Short$1,656.00Short Interest Ratio0.5 Days to CoverLast Record DateFebruary 15, 2025Outstanding Shares77,968,000 sharesShort Percent of Float0.06%Today's Trading Volume20,463 sharesAverage Trading Volume16,735 sharesToday's Volume Vs. Average122% Short Selling Guided Therapeutics? Sign up to receive the latest short interest report for Guided Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGTHP Short Interest Over TimeGTHP Days to Cover Over TimeGTHP Percentage of Float Shorted Over Time Guided Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/15/202513,800 shares $1,656.00 +40.8%0.1%0.5 $0.12 1/31/20259,800 shares $1,274.00 +25.6%N/A0.3 $0.13 1/15/20257,800 shares $1,113.45 No ChangeN/A0.8 $0.14 12/31/20247,800 shares $1,170.00 No ChangeN/A0.2 $0.15 11/15/2024400 shares $68.00 -96.7%N/A0 $0.17 10/31/202412,000 shares $2,400.00 -2.4%N/A0.2 $0.20 10/15/202412,300 shares $1,723.23 -6.1%N/A4.7 $0.14 9/30/202413,100 shares $2,292.50 +36.5%N/A1.4 $0.18 9/15/20249,600 shares $1,824.00 +146.2%N/A1 $0.19 8/31/20243,900 shares $538.20 +1,200.0%N/A0.3 $0.14 Get the Latest News and Ratings for GTHP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Guided Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/15/2024300 shares $35.37 -72.7%N/A0 $0.12 7/31/20241,100 shares $132.00 -38.9%N/A0.1 $0.12 7/15/20241,800 shares $239.28 No ChangeN/A0 $0.13 6/15/20242,000 shares $280.00 -52.4%N/A0 $0.14 5/31/20244,200 shares $420.00 -71.0%N/A0.2 $0.10 5/15/202414,500 shares $1,160.00 +137.7%N/A0.1 $0.08 4/30/20246,100 shares $664.90 -77.2%N/A0.5 $0.11 4/15/202426,700 shares $2,563.20 +256.0%N/A0.9 $0.10 3/31/20247,500 shares $866.25 No ChangeN/A0.2 $0.12 2/29/20246,400 shares $918.40 +392.3%N/A0.1 $0.14 2/15/20241,300 shares $187.33 No ChangeN/A0 $0.14 1/15/20241,300 shares $184.60 No ChangeN/A0.1 $0.14 12/31/20231,300 shares $199.55 -45.8%N/A0 $0.15 12/15/20232,400 shares $453.60 +242.9%N/A0.1 $0.19 11/30/2023700 shares $94.50 -70.8%N/A0 $0.14 11/15/20232,400 shares $323.40 -64.2%N/A0.1 $0.13 10/31/20236,700 shares $1,005.00 No ChangeN/A0.2 $0.15 9/15/20234,900 shares $686.00 -53.8%N/A0.3 $0.14 8/31/202310,600 shares $1,590.00 -33.8%N/A0.2 $0.15 8/15/202316,000 shares $2,161.60 -0.6%N/A0.6 $0.14 7/31/202316,100 shares $2,334.50 +26.8%N/A0.7 $0.15 7/15/202312,700 shares $2,667.00 +32.3%N/A1.3 $0.21 6/30/20239,600 shares $2,160.00 +47.7%N/A0.2 $0.23 6/15/20236,500 shares $1,040.00 -55.5%N/A0 $0.16 5/31/202314,600 shares $2,774.00 +89.6%N/A1.2 $0.19 5/15/20237,700 shares $1,309.00 -56.7%N/A0.1 $0.17 4/30/202317,800 shares $4,272.00 +17,700.0%N/A0.8 $0.24 4/15/2023100 shares $28.00 -96.9%N/A0 $0.28 3/31/20233,200 shares $736.00 +18.5%N/A0.1 $0.23 3/15/20232,700 shares $796.23 +2,600.0%N/A0.9 $0.29Now I look stupid. Real stupid... (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. 2/28/2023100 shares $29.00 -95.7%N/A0 $0.29 2/15/20232,300 shares $765.90 +76.9%N/A0.1 $0.33 1/31/20231,300 shares $450.32 No ChangeN/A0.1 $0.35 12/30/20221,200 shares $360.00 -93.9%N/A0 $0.30 12/15/202219,500 shares $6,431.10 -21.4%N/A2.9 $0.33 11/30/202224,800 shares $8,665.12 +13.2%N/A2.5 $0.35 11/15/202221,900 shares $6,132.00 +10.6%N/A1 $0.28 10/31/202219,800 shares $5,940.00 -2.0%N/A0.8 $0.30 10/15/202220,200 shares $9,090.00 -7.8%N/A3.5 $0.45 9/30/202221,900 shares $11,169.00 +10.6%N/A2.3 $0.51 9/15/202219,800 shares $10,543.50 No ChangeN/A2.8 $0.53 8/31/202219,800 shares $9,702.00 -1.5%N/A6.4 $0.49 8/15/202220,100 shares $11,658.00 +133.7%N/A2.4 $0.58 7/31/20228,600 shares $4,472.00 +855.6%N/A1 $0.52 7/15/2022900 shares $512.28 No ChangeN/A0 $0.57 6/15/2022900 shares $427.95 -76.3%N/A0.1 $0.48 5/31/20223,800 shares $1,938.00 +192.3%N/A0.1 $0.51 5/15/20221,300 shares $715.00 No ChangeN/A0.1 $0.55 3/31/2022300 shares $195.00 -83.3%N/A0 $0.65 3/15/20221,800 shares $918.00 +1,700.0%N/A0.2 $0.51 2/28/2022100 shares $52.50 No ChangeN/A0 $0.53 2/15/2022100 shares $62.50 No ChangeN/A0 $0.63 1/31/2022100 shares $60.00 -75.0%N/A0 $0.60 1/15/2022400 shares $240.00 +300.0%N/A0 $0.60 12/31/2021100 shares $58.02 No ChangeN/A0 $0.58 12/15/2021100 shares $64.94 No ChangeN/A0 $0.65 11/30/2021100 shares $67.50 -50.0%N/A0 $0.68 11/15/2021200 shares $114.02 +100.0%N/A0 $0.57 10/29/2021100 shares $57.00 No ChangeN/A0 $0.57 10/15/2021100 shares $54.00 No ChangeN/A0 $0.54 9/30/2021100 shares $55.99 -98.2%N/A0 $0.56 9/15/20215,400 shares $3,345.30 +17.4%N/A0.4 $0.62 8/31/20214,600 shares $2,529.54 +475.0%N/A0.2 $0.55 8/13/2021800 shares $410.16 +700.0%N/A0 $0.51 7/30/2021100 shares $59.00 -95.7%N/A0 $0.59 7/15/20212,300 shares $1,426.00 +35.3%N/A0.3 $0.62 6/30/20211,700 shares $1,071.00 +240.0%N/A0.2 $0.63 6/15/2021500 shares $331.30 +400.0%N/A0 $0.66 5/28/2021100 shares $59.25 No ChangeN/A0 $0.59 5/14/2021100 shares $64.00 -75.0%N/A0 $0.64 4/30/2021400 shares $276.04 No ChangeN/A0 $0.69 3/15/2021100 shares $75.00 -92.3%N/A0 $0.75 2/26/20211,300 shares $1,157.00 -81.4%N/A0 $0.89 2/12/20217,000 shares $3,500.00 -41.2%N/A0.3 $0.50 1/29/202111,900 shares $4,998.00 +5,850.0%N/A0.3 $0.42 1/15/202113,800 shares $5,533.80 +294.3%N/A0.2 $0.40 12/31/20206,600 shares $2,171.40 -52.2%N/A0.5 $0.33 12/15/202013,800 shares $2,497.80 +294.3%N/A0.2 $0.18 11/30/20203,500 shares $665.00 -78.7%N/A0.1 $0.19 11/15/202016,400 shares $4,608.40 +1,540.0%N/A0.6 $0.28Real Americans Don’t Wait on Wall Street’s Next Move (Ad)What's happening in the markets right now should concern every freedom-loving American who's worked hard and saved smart. Your 401(k) doesn't deserve to be dragged through the mud by tariffs, trade wars, reckless spending, and political standoffs. And you don't have to stand by while Wall Street plays roulette with your future.The Golden Path to Retirement gives you the whole story. 10/30/20201,000 shares $363.00 +11.1%N/A0.1 $0.36 10/15/2020900 shares $279.18 +125.0%N/A0.2 $0.31 9/30/2020400 shares $148.00 -91.8%N/A0.1 $0.37 9/15/20204,900 shares $1,813.00 -70.8%N/A0.5 $0.37 GTHP Short Interest - Frequently Asked Questions What is Guided Therapeutics' current short interest? Short interest is the volume of Guided Therapeutics shares that have been sold short but have not yet been closed out or covered. As of February 15th, traders have sold 13,800 shares of GTHP short. 0.06% of Guided Therapeutics' shares are currently sold short. Learn More on Guided Therapeutics' current short interest. What is a good short interest percentage for Guided Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.06% of Guided Therapeutics' floating shares are currently sold short. Is Guided Therapeutics' short interest increasing or decreasing? Guided Therapeutics saw a increase in short interest during the month of February. As of February 15th, there was short interest totaling 13,800 shares, an increase of 40.8% from the previous total of 9,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Guided Therapeutics' short interest compare to its competitors? 0.06% of Guided Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Guided Therapeutics: DarioHealth Corp. (9.48%), Spectral AI, Inc. (10.03%), Precision Optics Co., Inc. (0.17%), Envoy Medical, Inc. (1.06%), PolyPid Ltd. (0.03%), CollPlant Biotechnologies Ltd. (0.02%), NeuroOne Medical Technologies Co. (0.36%), Vaso Co. (0.03%), Nexalin Technology, Inc. (1.88%), NEXGEL, Inc. (2.52%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($25.81 billion), iShares 20+ Year Treasury Bond ETF ($10.38 billion), Strategy Incorporated ($7.74 billion), AppLovin Co. ($6.32 billion), Apollo Global Management, Inc. ($5.97 billion), Super Micro Computer, Inc. ($4.89 billion), Charter Communications, Inc. ($4.52 billion), Capital One Financial Co. ($3.94 billion), Schlumberger Limited ($3.19 billion), and Reddit, Inc. ($3.01 billion). View all of the most shorted stocks. What does it mean to sell short Guided Therapeutics stock? Short selling GTHP is an investing strategy that aims to generate trading profit from Guided Therapeutics as its price is falling. GTHP shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Guided Therapeutics? A short squeeze for Guided Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GTHP, which in turn drives the price of the stock up even further. How often is Guided Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GTHP, twice per month. The most recent reporting period available is February, 15 2025. More Short Interest Resources from MarketBeat Related Companies DarioHealth Short Squeeze Spectral AI Short Squeeze Precision Optics Short Squeeze Envoy Medical Short Squeeze PolyPid Short Squeeze CollPlant Biotechnologies Short Squeeze NeuroOne Medical Technologies Short Squeeze Vaso Short Squeeze Nexalin Technology Short Squeeze NEXGEL Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:GTHP) was last updated on 4/21/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guided Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guided Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GTHP Stock Free GTHP Stock Alerts